All Stories

  1. Concavity of the maximal expiratory flow-volume curve and incidence of COPD and respiratory symptoms: a population-based cohort study
  2. Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study
  3. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study
  4. COPD in Never-Smokers: BOLD Australia Study
  5. Risk factors and clinical characteristics of breathlessness in Australian adults: Data from the BOLD Australia study
  6. Respiratory Symptoms, Disease Burden, and Quality of Life in Australian Adults According to GOLD Spirometry Grades: Data from the BOLD Australia Study
  7. Clinical characteristics of adults with self-reported diagnosed asthma and/or COPD: data from the BOLD Australia Study
  8. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study
  9. Small for gestational age is associated with reduced lung function in middle age: A prospective study from first to fifth decade of life
  10. Relationship between concavity of the flow-volume loop and small airway measures in smokers with normal spirometry
  11. Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study
  12. Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma
  13. Childhood lung function as a determinant of menopause-dependent lung function decline
  14. Normal limits for oscillometric bronchodilator responses and relationships with clinical factors
  15. Prevalence of chronic obstructive pulmonary disease with breathlessness in Australia: weighted using the 2016 Australian census
  16. Undiagnosed and Misdiagnosed Chronic Obstructive Pulmonary Disease: Data from the BOLD Australia Study
  17. Bronchodilator reversibility as a diagnostic test for adult asthma: Findings from the population-based Tasmanian Longitudinal Health Study
  18. Early Age at Natural Menopause Is Related to Lower Post-Bronchodilator Lung Function. A Longitudinal Population-based Study
  19. Lifetime Risk Factors for Pre- and Post-Bronchodilator Lung Function Decline: A Population-based Study
  20. Childhood pneumonia, pleurisy and lung function: a cohort study from the first to sixth decade of life
  21. Early menarche is associated with lower adult lung function: A longitudinal cohort study from the first to sixth decade of life
  22. Low levels of air pollution (NO2) and reduced lung function in middle-age
  23. Occupational exposure to solvents and lung function decline: A population based study
  24. Early-life exposure to sibling modifies the relationship between CD14 polymorphisms and allergic sensitization
  25. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
  26. Childhood measles contributes to post-bronchodilator airflow obstruction in middle-aged adults: A cohort study
  27. Improved spirometric detection of small airway narrowing: concavity in the expiratory flow–volume curve in people aged over 40 years
  28. Atopy in people aged 40 years and over: Relation to airflow limitation
  29. Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age
  30. Bronchial hyperresponsiveness and obesity in middle age: insights from an Australian cohort
  31. Occupational exposure and COPD
  32. The Dose–Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations
  33. Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study [Corrigendum]
  34. Preterm birth and low birth weight continue to increase the risk of asthma from age 7 to 43
  35. Current asthma contributes as much as smoking to chronic bronchitis in middle age: a prospective population-based study
  36. Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study
  37. Cohort Profile: The Tasmanian Longitudinal Health STUDY (TAHS)
  38. Mother's smoking and complex lung function of offspring in middle age: A cohort study from childhood
  39. Hormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort study
  40. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study
  41. Assessing the Performance of Two Lung Age Equations on the Australian Population: Using Data From the Cross-Sectional BOLD-Australia Study
  42. Domestic airborne pollutants and asthma and respiratory symptoms in middle age
  43. Automated Estimation and Analysis of Lung Function Test Parameters from Spirometric Data for Respiratory Disease Diagnostics
  44. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study
  45. Asthma diagnosis and treatment – 1016. Is atopy in people aged 40 and over related to fixed airflow obstruction?
  46. The Interplay between the Effects of Lifetime Asthma, Smoking, and Atopy on Fixed Airflow Obstruction in Middle Age
  47. Childhood Infections and the Risk of Asthma
  48. Poor lung function and tonsillectomy in childhood are associated with mortality from age 18 to 44
  49. Adherence to asthma management guidelines by middle-aged adults with current asthma
  50. Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD
  51. Effects of Feedback on Spirometry in Primary Care on Motivation for Smoking Cessation
  52. Relevance of the hygiene hypothesis to early vs. late onset allergic rhinitis
  53. Prediction equations for single breath diffusing capacity (Tlco) in a middle aged caucasian population
  54. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related
  55. Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle age
  56. Tolerance and rebound with zafirlukast in patients with persistent asthma
  57. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD
  58. Expert-Driven Knowledge Discovery
  59. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study
  60. A Fast Heuristic Algorithm for Similarity Search in Large DNA Databases
  61. Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
  62. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction
  63. Associations between reduced diffusing capacity and airflow obstruction in community-based subjects
  64. Response to the letter: Value of recommended spirometer accuracy checks on office spirometers in primary care unknown
  65. β2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults
  66. Airway distensibility in normal and asthmatic subjects and partitioning of the Fowler dead space
  67. National survey of spirometer ownership and usage in general practice in Australia
  68. Stability of the EasyOne ultrasonic spirometer for use in general practice
  69. How have we been managing chronic obstructive pulmonary disease in Australia?
  70. Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis
  71. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease
  72. High justification for universal stringent precautions in lung function testing
  73. Author's reply
  74. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation
  75. Variation in barometric pressure in Melbourne does not significantly affect the BTPS correction factor
  76. Decreased lung capillary blood volume post-exercise is compensated by increased membrane diffusing capacity
  77. Influence of High Altitude on Lung Development and Function
  78. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease
  79. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients
  80. Infection control of lung function equipment: a practical approach
  81. Management of chronic obstructive pulmonary disease in the twenty-first century
  82. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma
  83. European Community Respiratory Health Survey calibration project of dosimeter driving pressures
  84. Airway distensibility in healthy and asthmatic subjects: effect of lung volume history
  85. Respiratory function in lambs after in utero treatment of lung hypoplasia by tracheal obstruction
  86. Hypoxemia and Hypercapnia During Exercise and Sleep in Patients With Cystic Fibrosis
  87. A critical evaluation of the MefarTM dosimeter
  88. Postnatal development of respiratory function in lambs studied serially between birth and 8 weeks
  89. Nebulizer calibration using lithium chloride: an accurate, reproducible and user-friendly method
  90. Differences in aerosol output and airways responsiveness between the DeVilbiss 40 and 45 hand held nebulisers.
  91. Evaluation of six oxygen concentrators.
  92. An Air-Enti Ainment Device for Preparing Precision Gas Mixtures
  93. An inexpensive constant flow injector
  94. Diagnostic Strategies